Articles

High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL

Hematology Department, Versailles Hospital
Sorbonne Université, AP-HP, Saint-Antoine Hospital, Hematology Department, UMRS 938, INSERM,Paris
Hematology Department, CHU de Bordeaux, Bordeaux
Hematology Department, CHU de Toulouse, Toulouse
Hematology Department, CHU de Nantes, Nantes
Hematology Department, CHU d'Angers, Angers
Hematology Departement, CHU de Rennes, Rennes
Hematology Departement, CHU de Nice, Nice
Hematology Departement, Lyon Sud Hospital, Pierre Benite
Hematology Departement, Pitié Salpêtrière Hospital, APHP, Paris
Hematology Departement, Gustave Roussy, Villejuif
Hematology Departement, Orléans Hospital, Orléans
GRAALL, CHU de Lyon, Lyon
Hematology Lab, CHU de Rennes, Rennes
Hematology Lab, CHU de Toulouse, Toulouse
Hematology Lab, Saint-Louis Hospital, APHP, Paris
Adult Hematology Department, Saint-Louis Hospital, APHP, URP3518, Institut de Recherche Saint-Louis, Université de Paris, Paris
Hematology Adolescent and Young Adult Unit, Saint-Louis Hospital, APHP, URP3518, Institut de Recherche Saint-Louis, Université de Paris, Paris
Haematologica Early view Mar 10, 2022 https://doi.org/10.3324/haematol.2021.280078